אולתוטון 30 מ"ג - Olatuton 30 mg
×××ר××
×צפ××× ×××××¢ ××ר×× ×ר×פ××× ×ש ××××× ×¡ ××ש××× ×. ×× ××× × ×¨×©×× ××× ×¡ ××רש×× ×ר×פ××× ××× ×©× ×קצ××¢×ת רפ×××××.
× ×ª×× × ×ª×¨×פ×
×××¨×©× 
| ××× ×× ×× × ×ספ×× | |
|---|---|
| ק×××¦× ×¤×¨×ק×××××ת (ATC4) | H01CB Somatostatin and analogues |
| ×ר××× ×¤×¢×× (ATC5) | Â
|
| צ×רת ××ª× | ת××-×¢×××× - INTRAGLUTEALLY |
| צ×רת ××× ×× | ×××§× ×××ס ×××× ×ª תר×××£ ×ש×ר×ר ××××©× ×××רק×, POWDER AND SOLVENT FOR PROLONGED-RELEASE SUSPENSION FOR INJECTION ××× ×עת ××× ×× ×תר ×× ×רע×× ×ש ××××× ×ת ×תר××¤× ××ת×× ×××× ×× ××××××¥ ××¤× ×©××פ××¢ ××¢××× ×צר×× |
| ×ת×××× | ⢠Treatment of acromegaly in patients already adequately controlled on standard doses of Octreotide S.C. Patients in whom surgery or radiotherapy are inappropriate or ineffective, or who are in the latency period before radiotherapy becomes fully effective. ⢠Endocrine gastro-entero- pancreatic (GEP) tumors, carcinoid tumors. |
| ×¢××× ×ר××¤× ××××ר×ת ××¢××× |
  |
| ×¢××× ×צר×× |  |
|---|
| ער××× ××××ק×רפ××× | ער××× ×§×©×ר×× ××××ק×רפ××× |
|---|---|
| ×××ת×××× 30 ×"× ××××ר ××©×¨× ××ר×××ת |
| ××פ×ש ×××ר×× | ×××ר×× ×-PubMed |
|---|---|
| ××××¢ ×רשת | RxList WebMD Drugs.com |
| ×©× ××¦×¨× | TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL |
| ×©× ××¢× ×ר×ש×× | ABIC MARKETING LTD, ISRAEL |
| ר×ש××× | ת×ר×× ××ש×: 5/2019. ר×ש××× ×ת×ר××: |
| ת×ר×× ×¢×××× ××ר×× | 14/06/2024 |
השינוי האחרון נעשה בֹ־14 ביוני 2024 ב־06:41